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To the editors,
We appreciate the opportunity to respond to the letter
regarding our article: ‘‘Injection therapy and denervation
procedures for chronic low-back pain: a systematic
review’’ [1]. This letter challenges the clinical value of our
review, suggesting that the choice of inclusion and exclu-
sion criteria displays a lack of clinical expertise within the
review team. This is supported by claims that we have
compared the results from trials evaluating pain syndromes
with different underlying mechanisms and analysed treat-
ments with no indication in a clinical setting.
As researchers, we fully support the inclusion of dif-
ferent stakeholders, including clinical experts and experi-
enced methodologists, in the design and conduct of
systematic reviews. However, we feel that the letter is
unjustiﬁed in criticising our review team for not producing
clinically relevant results. The concerns are related to
decisions, which were made by our team about the types of
interventions and the population to be studied in the sys-
tematic review. These were made in the attempt to provide
an independent overview (commissioned by the Dutch
Health Insurance Council) of all relevant studies on
injection therapy and denervation procedures for chronic
low-back pain, in preference to a more selective review on
only one speciﬁc intervention. We are conﬁdent that our
methods and conclusions are scientiﬁcally correct and
clinically relevant. They are also consistent with other
systematic reviews and clinical guidelines which were
conducted and published by clinicians with ample expertise
in low back pain management and research [2, 3].
The challenges faced when systematically reviewing the
evidence on interventions for chronic low-back pain
include the lack of clear information about the causes of
chronic low-back pain and poor understanding of patient
heterogeneity. While recent recommendations by the Ini-
tiative on Methods, Measurement, and Pain Assessment in
Clinical Trials (IMMPACT) group support a ‘‘mechanism-
based’’ treatment approach in which therapeutic interven-
tions target the speciﬁc mechanisms of a patient’s pain, the
group also acknowledges that it is not yet possible to fully
identify these mechanisms and to specify which treatments
would target them [4]. While these recommendations
hopefully lead to better randomized trials in the future,
many trials that have already been published do not fulﬁl
the IMMPACT recommendations and this is reﬂected in
systematic reviews. With regard to chronic low-back pain,
it is generally accepted that a speciﬁc mechanism for the
pain cannot be identiﬁed in a large majority of patients [5].
A distinction is often made, however, based on the duration
of the pain as acute, sub-acute, and chronic low-back pain.
As our review focused on patients with chronic low-back
pain, it is misguided to criticise our review for not
including studies on patients with sub-acute low-back pain.
Due to the heterogeneity of the interventions evaluated
by the primary studies included in our review, an attempt to
improve readability was made by grouping the results in
broad anatomical areas (intervertebral disc, facet joints,
epidural space, spinal muscles). As can be observed, studies
of different treatment options were not pooled and no
conclusions are made regarding the evidence for injection
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tomical areas. A degree of prudence was exercised to ensure
that the conclusions of the systematic review did not
extrapolate beyond what was available in the primary
studies. Despite the claim that some of the interventions
included in the review have no indication in clinical prac-
tice, in general, the evidence for injection therapy and
denervation procedures is limited and recent clinical
guidelines and published systematic reviews [2, 3, 6] have
highlighted this.
Unfortunately, many studies in this ﬁeld suffer from
poor reporting and substantial methodological shortcom-
ings and this is reﬂected in the lack of high-quality evi-
dence. While it is easy to criticise a systematic review for
not producing clinically relevant results, we are conﬁdent
that our review has objectively evaluated the available
primary studies. This systematic review shows that the
methodological quality and clinical relevance of original
trials on injection therapy and denervation techniques for
chronic low-back pain should be improved. We maintain
that the clinical value of this review lies in the ﬁnding that
at present there is limited evidence to support the use of
injection therapy and denervation procedures as interven-
tions for chronic low-back pain.
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